Dr. Tahir's Laxative Formula #2 capsules
Natural health product licensed in Canada
- Licence holder
- Toronto College of Naturopathic Medicine Inc.
- NPN or DIN-HM
- 80006243
- Status
- Active licence
- Licence date
- 20 June 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Plantago ispaghula | Not specified | Not calculated |
Non-medicinal ingredients
Hypromellose, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Used as a laxative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if you are taking any prescription medication. Oral products product action in 6 to 12 hours..
- Contre-indications
Do not take any type of laxative for more than one (1) week, unless your physician has ordered a special schedule for you. Do not use in the presence of abdominal pain, nausea, fever or vomiting (this refers to signs appendicitis or inflamed bowel). Do not swallow in dry form. Do not use if you are prgnant or breastfeeding. Do not take within two (2) hours of another medicine because the desired effect of the other medicine may be reduced.
- Effets indésirables connus
Overuse or extended use may cause dependence for bowel function. This product may cause an allergic reaction in people sensitive to inhaled or ingested psyllium powder. AVOID INHALATION.
Source
Official Health Canada record, licence 80006243
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.